Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Globalization and Health
Published in: Globalization and Health 1/2015

Open Access 01-12-2015 | Commentary

Design, testing, and scale-up of medical devices for global health: negative pressure wound therapy and non-surgical male circumcision in Rwanda

Authors: Gita N Mody, Vincent Mutabazi, Danielle R Zurovcik, Jean Paul Bitega, Sabin Nsanzimana, Sardis H Harward, Claire M Wagner, Cameron T Nutt, Agnes Binagwaho

Published in: Globalization and Health | Issue 1/2015

Login to get access

Excerpt

Products with high efficacy and low cost are desirable in all market sectors and environments, particularly in settings where resources are limited. The health sectors of developing nations are an example of this basic economic principle as constrained financial and human resources must be budgeted toward large (and often, growing) populations’ health needs. However, the cost and quality characteristics that are absolutely necessary in resource-limited settings (RLS) remain highly desirable in wealthy markets as well. Consequently, technologies and strategies designed in RLS are frequently adopted by high-income nations, a process termed “reverse innovation” [1-4]. …
Literature
1.
Howitt P, Darzi A, Yang GZ, Ashrafian H, Atun R, Barlow J, et al. Technologies for global health. Lancet. 2012;380(9840):507–35.CrossRefPubMed
2.
Binagwaho A, Nutt CT, Mutabazi V, Karema C, Nsanzimana S, Gasana M, et al. Shared learning in an interconnected world: innovations to advance global health equity. Glob Health. 2013;9:36.CrossRef
3.
Syed SB, Dadwal V, Martin G. Reverse innovation in global health systems: towards global innovation flow. Glob Health. 2013;9:36.CrossRef
4.
Syed SB, Dadwal V, Rutter P, Storr J, Hightower JD, Gooden R, et al. Developed-developing country partnerships: benefits to developed countries? Glob Health. 2012;8:17.CrossRef
5.
Binagwaho A, Wagner CM, Gatera M, Karema C, Nutt CT, Ngabo F. Achieving high coverage in Rwanda’s national human papillomavirus vaccination programme. Bull World Health Organ. 2012;90:623–8.CrossRefPubMedCentralPubMed
6.
Binagwaho A, Ngabo F, Wagner CM, Mugeni C, Gatera M, Nutt CT, et al. Integration of comprehensive women’s health programmes into health systems: cervical cancer prevention, care and control in Rwanda. Bull World Health Organ. 2013;91:697–703.CrossRefPubMedCentralPubMed
7.
8.
Ngabo F, Nguimfack J, Nwaigwe F, Mugeni C, Muhoza D, Wilson DR, et al. Designing and implementing an innovative SMS-based alert system (RapidSMS-MCH) to monitor pregnancy and reduce maternal and child deaths in Rwanda. Pan Afr Med J. 2012;13:31.PubMedCentralPubMed
9.
Logie DE, Rowson M, Ndagije F. Innovations in Rwanda’s health system: looking to the future. Lancet. 2008;372(9634):256–61.CrossRefPubMed
10.
Farmer PE, Nutt CT, Wagner CM, Sekabaraga C, Nuthulaganti T, Weigel JL, et al. Reduced premature mortality in Rwanda: lessons from success. BMJ. 2013;346. Doi:10.1136/bmj.f65
11.
Orgill DP, Bayer LR. Negative pressure wound therapy: past, present and future. Int Wound J. 2013;10 Suppl 1:15–9.CrossRefPubMed
12.
Xie X, McGregor M, Dendukuri N. The clinical effectiveness of negative pressure wound therapy: a systematic review. J Wound Care. 2010. DOI:10.12968/jowc.2010.19.11.79697.
13.
Zurovcik D. Development of a simplified negative pressure wound device. Boston: Massachusetts Institute of Technology; 2007.
14.
Zurovcik D. Development of simplified negative pressure wound therapy device for low-resource settings. Seattle: Global Humanitarian Technology Conference; 2011.CrossRef
15.
Fong KD, Hu D, Eichstadt S, Gupta DM, Pinto M, Gurtner GC, et al. The SNaP system: biomechanical and animal model testing of a novel ultraportable negative-pressure wound therapy system. Plast Reconstr Surg. 2010;125(5):1362–71.CrossRefPubMed
16.
Hutton DW, Sheehan P. Comparative effectiveness of the SNaP wound care system. Int Wound J. 2011;8(2):196–205.CrossRefPubMed
17.
Webster R, Ely PB, Milani A, Filho GP, Valiati A, Filho AM, et al. Alternative materials in vacuum-assisted closure. Plast Reconstr Surg. 2011;128(6):784e-5e.
18.
Tobian AAR, Kacker S, Quinn TC. Male circumcision: a globally relevant but under-utilized method for the prevention of HIV and other sexually transmitted infections. Annu Rev Med. 2014;65:293–306.CrossRefPubMed
19.
Mills E, Cooper C, Anema A, Guyatt G. Male circumcision for the prevention of heterosexually acquired HIV infection: a meta-analysis of randomized trials involving 11 050 men. HIV Med. 2008;9:332–5.CrossRefPubMed
20.
Gray RH, Kigozi G, Serwadda D, Makumbi R, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369(9562):657–66.CrossRefPubMed
21.
Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Lancet. 2007;369(9562):643–56.CrossRefPubMed
22.
Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med. 2005;2, e298.CrossRefPubMedCentralPubMed
23.
24.
25.
26.
Bitega JP, Ngeruka ML, Hategekimana T, Asiimwe A, Binagwaho A. Safety and efficacy of the PrePex device for rapid scale-up of male circumcision for HIV prevention in resource-limited settings. J Acquir Immune Defic Syndr. 2011;28(5):e127–34.CrossRef
27.
Mutabazi V, Kaplan SA, Rwamasirabo E, Bitega JP, Ngeruka ML, Savio D, et al. HIV prevention: male circumcision comparison between a nonsurgical device to a surgical technique in resource-limited settings: a prospective, randomized, nonmasked trial. J Acquir Immune Defic Syndr. 2012;61(1):49–55.CrossRefPubMed
28.
Mutabazi V, Kaplan SA, Rwamasirabo E, Bitega JP, Ngeruka ML, Savio D, et al. One-arm, open-label, prospective, cohort field study to assess the safety and efficacy of the PrePex device for scale-up of nonsurgical circumcision when performed by nurses in resource-limited settings for HIV prevention. J Acquir Immune Defic Syndr. 2013;63(3):315–22.CrossRefPubMed
29.
Duffy K, Galukande M, Wooding N, Dea M, Coutinho A. Reach and cost-effectiveness of the PrePex device for safe male circumcision in Uganda. PLoS One. 2013;8, e63134.CrossRefPubMedCentralPubMed
30.
Njeuhmeli E, Kripke K, Hatzold K, Reed J, Edgil D, Jaramillo J, et al. Cost analysis of integrating the PrePex medical device into a voluntary medical male circumcision program in Zimbabwe. PLoS One. 2014;9, e82533.CrossRefPubMedCentralPubMed
31.
Republic of Rwanda Ministry of Health. Rwanda HIV and AIDS National Strategic Plan, July 2013-June 2018. Kigali: Republic of Rwanda Ministry of Health; 2013.
32.
Murray CLJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380(9859):2197–223.CrossRef
33.
Perry L, Malkin R. Effectiveness of medical equipment donations to improve health systems: how much medical equipment is broken in the developing world? Med Biol Eng Comput. 2011;49(7):719–22.CrossRefPubMed
34.
Govindarajan V, Trimble C. Reverse innovation: create far from home, win everywhere, vol. XV. Boston: Harvard Business Press; 2012. p. 229.
35.
Govindarajan V, Ramamurti R. Reverse innovation, emerging markets and global strategy. Glob Strateg J. 2011;1:191–205.CrossRef
36.
Hagander LE, Hughes CD, Nash K, Ganjawalla K, Linden A, Martins Y, et al. Surgeon migration between developing countries and the United States: train, retain, and gain from brain drain. World J Surg. 2013;37(1):14–23.CrossRefPubMed
37.
38.
Binagwaho A, Kyamanywa P, Farmer PE, Nuthulaganti T, Umubyeyi B, Nyemazi JP, et al. The Human Resources for Health program in Rwanda – a new partnership. N Engl J Med. 2013;369(21):2054–9.CrossRefPubMed
39.
Binagwaho A, Muhimpundu MA, Bukhman G, for the NCD Synergies Group. 80 under 40 by 2020: an equity agenda for NCDs and injuries. Lancet. 2014;383(9911):3–4.CrossRefPubMed
Metadata
Title
Design, testing, and scale-up of medical devices for global health: negative pressure wound therapy and non-surgical male circumcision in Rwanda
Authors
Gita N Mody
Vincent Mutabazi
Danielle R Zurovcik
Jean Paul Bitega
Sabin Nsanzimana
Sardis H Harward
Claire M Wagner
Cameron T Nutt
Agnes Binagwaho
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Globalization and Health / Issue 1/2015
Electronic ISSN: 1744-8603
DOI
https://doi.org/10.1186/s12992-015-0101-4

Other articles of this Issue 1/2015

Globalization and Health 1/2015 Go to the issue

Research

Towards a simple typology of international health partnerships

Research

“I get hungry all the time”: experiences of poverty and pregnancy in an urban healthcare setting in South Africa

Research

An evaluation of the benefits to a UK Health Care Trust working in a partnership with a hospital in Northern Uganda: International partnership working in mental health

Research

Policy implications of medical tourism development in destination countries: revisiting and revising an existing framework by examining the case of Jamaica

Research

The role of trade and investment liberalization in the sugar-sweetened carbonated beverages market: a natural experiment contrasting Vietnam and the Philippines

Research

Diplomatic advantages and threats in global health program selection, design, delivery and implementation: development and application of the Kevany Riposte